Background: Invasive candidiasis is an increasing problem in neonatal intensive care units worldwide and is an important cause of morbidity, mortality and prolongation of hospital stay. Despite ...

Background: Candida species are the third most common cause of pediatric health care–associated bloodstream infection in the United States and Europe. To our knowledge, this report from the ...

Current Infectious Disease Society of America guidelines for the treatment of invasive candidiasis recommend a minimum ...

The Infectious Diseases Society of America has published updated guidelines in the journal Clinical Infectious Diseases on treating candidiasis, a serious, life-threatening fungal infection.

Rezafungin is a novel, once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections The Medicines and Healthcare Products Regulatory Agency (MHRA) filing ...

Invasive candidiasis, which in many patients represents a life-threatening condition, is “largely a disease of medical progress,” according to the Guidelines. Risk factors include the use of ...

The FDA gave the greenlight to the long-acting antifungal rezafungin (Rezzayo), the first new treatment option for candidemia and invasive candidiasis to gain approval in over a decade, Cidara ...

Credit: Melinta Therapeutics. Rezzayo is supplied as a solid (cake or powder) in a single-dose vial containing 200mg of rezafungin. Rezzayo ™ (rezafungin for injection) is now available for the ...

Michail Lionakis, MD, ScD, chief of the fungal pathogenesis section at the National Institutes of Health, is the senior author of this study. Invasive candidiasis is a life-threatening fungal ...

Invasive candidiasis represents a spectrum of life-threatening fungal infections that commonly afflict critically ill patients. It encompasses candidemia—bloodstream invasion by Candida species—and ...

Please provide your email address to receive an email when new articles are posted on . Among patients with IFI, yeast on donor culture and prolonged length of stay were associated with early IC risk.